Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
163,384,965
-
Total 13F shares
-
111,635,776
-
Share change
-
-923,077
-
Total reported value
-
$2,630,327,572
-
Put/Call ratio
-
378%
-
Price per share
-
$23.56
-
Number of holders
-
199
-
Value change
-
-$39,471,758
-
Number of buys
-
97
-
Number of sells
-
96
Institutional Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q4 2024
As of 31 Dec 2024,
Dyne Therapeutics, Inc. - Common Stock (DYN) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,635,776 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, FMR LLC, BlackRock, Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., RTW INVESTMENTS, LP, STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
199
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.